ATR and non-small cell lung carcinoma: Similarly, AZD6738 caused a concentration-dependent synergy with cisplatin in K-ras mutant, ATM deficient NSCLC cell lines [92] and ETP-46464, another ATR inhibitor substantially increased cisplatin cytotoxicity in a panel of ovarian, endometrial and cervical cancer cell lines.